{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:09:34Z","timestamp":1771034974912,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.psychres.2023.115586","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:21:48Z","timestamp":1699024908000},"page":"115586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dysregulation of the endogenous cannabinoid system following opioid exposure"],"prefix":"10.1016","volume":"330","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-8001","authenticated-orcid":false,"given":"Ardavan","family":"Mohammad Aghaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1965-2001","authenticated-orcid":false,"given":"Alexandra","family":"Saali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-5276","authenticated-orcid":false,"given":"Maria Alejandra","family":"Canas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-7412","authenticated-orcid":false,"given":"Jeremy","family":"Weleff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak Cyril","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahita","family":"Bassir Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115586_bib0001","article-title":"Provisional drug overdose death counts","volume":"12","author":"Ahmad","year":"2021","journal-title":"Natl. Cent. Health Stat."},{"issue":"39","key":"10.1016\/j.psychres.2023.115586_bib0002","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1523\/JNEUROSCI.1686-13.2013","article-title":"Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus mu-opiate receptor dependent mechanisms","volume":"33","author":"Ahmad","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0003","first-page":"433","article-title":"The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats","volume":"34","author":"Altun","year":"2015","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.psychres.2023.115586_bib0004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2013.05.035","article-title":"Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents","volume":"247","author":"Alvaro-Bartolome","year":"2013","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0006","series-title":"Opioid Addiction","author":"Azadfard","year":"2021"},{"key":"10.1016\/j.psychres.2023.115586_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0008","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ilar\/ilx014","article-title":"Utility of nonhuman primates in substance use disorders research","volume":"58","author":"Banks","year":"2017","journal-title":"ILAR J."},{"key":"10.1016\/j.psychres.2023.115586_bib0009","series-title":"Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma","first-page":"3","author":"Bassir Nia","year":"2019"},{"key":"10.1016\/j.psychres.2023.115586_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00253-010-2580-9","article-title":"Comparison of hybridization methods and real-time PCR: their value in animal cell line characterization","volume":"87","author":"B\u00f6hm-Hofst\u00e4tter","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"14","key":"10.1016\/j.psychres.2023.115586_bib0011","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1523\/JNEUROSCI.4403-06.2007","article-title":"Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration","volume":"27","author":"Caille","year":"2007","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.psychres.2023.115586_bib0012","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1111\/j.1460-9568.2003.02961.x","article-title":"SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats","volume":"18","author":"Caille","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.psychres.2023.115586_bib0013","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.addbeh.2010.03.019","article-title":"Systematic review of prospective studies investigating \"remission\" from amphetamine, cannabis, cocaine or opioid dependence","volume":"35","author":"Calabria","year":"2010","journal-title":"Addict. Behav."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0014","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2019.02.002","article-title":"ABHD6: its place in endocannabinoid signaling and beyond","volume":"40","author":"Cao","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"23","key":"10.1016\/j.psychres.2023.115586_bib0015","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.4152-06.2007","article-title":"Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation","volume":"27","author":"Cheer","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/0471142301.ns0701s47","article-title":"Overview of brain microdialysis","volume":"47","author":"Chefer","year":"2009","journal-title":"Curr. Protocols Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0018","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"9600","key":"10.1016\/j.psychres.2023.115586_bib0019","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.psychres.2023.115586_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fpsyt.2019.00063","article-title":"The endocannabinoid system and cannabidiol's promise for the treatment of substance use disorder","volume":"10","author":"Chye","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115586_bib0021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00213-003-1422-1","article-title":"Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats","volume":"168","author":"De Vries","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)02483-4","article-title":"Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404","volume":"454","author":"Del Arco","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0024","series-title":"GTP\u03b3S Binding assays. Assay Guidance Manual","author":"DeLapp","year":"2012"},{"issue":"5","key":"10.1016\/j.psychres.2023.115586_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41587-021-01074-4","article-title":"A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo","volume":"40","author":"Dong","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.psychres.2023.115586_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109451","article-title":"Imaging the endocannabinoid signaling system","volume":"367","author":"Dudok","year":"2022","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0027","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0958-1669(00)00078-1","article-title":"Proteomic analysis","volume":"11","author":"Dutt","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"issue":"7","key":"10.1016\/j.psychres.2023.115586_bib0028","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2","volume":"25","author":"Fattore","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0029","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00186-7","article-title":"Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels","volume":"66","author":"Gonzalez","year":"2002","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/1355621031000117383","article-title":"Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats","volume":"8","author":"Gonzalez","year":"2003","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psychres.2023.115586_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.12.008","article-title":"Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists","volume":"116","author":"Grenald","year":"2017","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.psychres.2023.115586_bib0032","doi-asserted-by":"crossref","first-page":"pyw068","DOI":"10.1093\/ijnp\/pyw068","article-title":"The CB1 neutral antagonist AM4113 retains the therapeutic efficacy of the inverse agonist rimonabant for nicotine dependence and weight loss with better psychiatric tolerability","volume":"19","author":"Gueye","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0033","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2003.07.005","article-title":"The [35S] GTP\u03b3S binding assay: approaches and applications in pharmacology","volume":"74","author":"Harrison","year":"2003","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41401-018-0059-x","article-title":"Cannabinoid CB(1) receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats","volume":"40","author":"He","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1254\/jphs.08244FP","article-title":"\u03bc-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis","volume":"108","author":"Hojo","year":"2008","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0036","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tips.2013.01.004","article-title":"What's conditioned in conditioned place preference?","volume":"34","author":"Huston","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2023.115586_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173544","article-title":"The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence","volume":"886","author":"Iyer","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0039","doi-asserted-by":"crossref","first-page":"288","DOI":"10.55782\/ane-2014-1994","article-title":"Expression and localization of cannabinoid receptor 1 in rats' brain treated with acute and repeated morphine","volume":"74","author":"Jin","year":"2014","journal-title":"Acta Neurobiol. Exp."},{"issue":"5","key":"10.1016\/j.psychres.2023.115586_bib0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.psychres.2023.115586_bib0041","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","article-title":"Targeting the endocannabinoid system in psychiatric illness","volume":"36","author":"Katzman","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.psychres.2023.115586_bib0042","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2023.115586_bib0043","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2019.00262","article-title":"Understanding addiction using animal models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0044","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psychres.2023.115586_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120094","article-title":"Looking beyond the opioid receptor: a desperate need for new treatments for opioid use disorder","volume":"432","author":"Lee","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0046","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.118.113233","article-title":"Cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal","volume":"95","author":"Li","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0047","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2017.02.025","article-title":"Differential expression of endocannabinoid system-related genes in the dorsal hippocampus following expression and reinstatement of morphine conditioned place preference in mice","volume":"643","author":"Li","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2023.115586_bib0048","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2018.08.009","article-title":"Factors associated with methadone maintenance therapy discontinuation among people who inject drugs","volume":"94","author":"Lo","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/138945010790980312","article-title":"Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors","volume":"11","author":"Lopez-Moreno","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.psychres.2023.115586_bib0050","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"issue":"7","key":"10.1016\/j.psychres.2023.115586_bib0051","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0052","first-page":"177","article-title":"Animal models of substance abuse and addiction: implications for science, animal welfare, and society","volume":"60","author":"Lynch","year":"2010","journal-title":"Comp. Med."},{"issue":"166","key":"10.1016\/j.psychres.2023.115586_bib0053","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0054","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nn2042","article-title":"Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum","volume":"11","author":"Maccarrone","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.psychres.2023.115586_bib0055","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002","article-title":"Cannabinoid addiction: behavioral models and neural correlates","volume":"22","author":"Maldonado","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2023.115586_bib0056","series-title":"Can Proteomics Retire the Western Blot?","first-page":"3065","author":"Mann","year":"2008"},{"key":"10.1016\/j.psychres.2023.115586_bib0057","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2023.115586_bib0058","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0059","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","article-title":"Endocannabinoid system, stress and HPA axis","volume":"834","author":"Micale","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drugalcdep.2013.08.010","article-title":"Perceived stress and substance use in methadone-maintained smokers","volume":"133","author":"Moitra","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0061","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12031-016-0716-9","article-title":"CB1 cannabinoid agonist (WIN55,212-2) within the basolateral amygdala induced sensitization to morphine and increased the level of mu-opioid receptor and c-fos in the nucleus accumbens","volume":"58","author":"Molaei","year":"2016","journal-title":"J. Mol. Neurosci."},{"issue":"03","key":"10.1016\/j.psychres.2023.115586_bib0062","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/a-1675-3494","article-title":"Endocannabinoid modulation using monoacylglycerol lipase inhibition in tourette syndrome: a phase 1 randomized, placebo-controlled study","volume":"55","author":"M\u00fcller-Vahl","year":"2022","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0063","first-page":"254","article-title":"Delta9-tetrahydrocannabinol and some CNS depressants: evidence for cross-tolerance in the rat","volume":"207","author":"Newman","year":"1974","journal-title":"Arch. Internationales de Pharmacodynamie et de Th\u00e9rapie"},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0064","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","article-title":"Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006","volume":"39","author":"Nosyk","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.psychres.2023.115586_bib0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.psychres.2023.115586_bib0066","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/AJP.0b013e318219799a","article-title":"A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction","volume":"27","author":"Ostenfeld","year":"2011","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.psychres.2023.115586_bib0067","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2019.05.026","article-title":"Stress, craving and mood as predictors of early dropout from opioid agonist therapy","volume":"202","author":"Panlilio","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.psychres.2023.115586_bib0068","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.psychres.2023.115586_bib0069","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/ejn.12174","article-title":"Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered \u2018wanting'for reward: entire core and medial shell mapped as substrates for PIT enhancement","volume":"37","author":"Peci\u00f1a","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psychres.2023.115586_bib0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-052220-021800","article-title":"Endocannabinoid-based therapies","volume":"62","author":"Piomelli","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0071","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.111.181370","article-title":"Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice","volume":"339","author":"Ramesh","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psychres.2023.115586_bib0072","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0091-679X(04)74024-8","article-title":"Detection of mRNA by in situ hybridization and RT-PCR","volume":"74","author":"Ransick","year":"2004","journal-title":"Methods Cell Biol."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0073","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus","volume":"21","author":"Rodriguez","year":"2001","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0074","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0376-8716(98)00036-2","article-title":"Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S] GTP\u03b3S binding in morphine-dependent mice","volume":"50","author":"Romero","year":"1998","journal-title":"Drug Alcohol Depend."},{"issue":"15","key":"10.1016\/j.psychres.2023.115586_bib0075","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1097\/00001756-199710200-00007","article-title":"Modulation of rat brain cannabinoid receptors after chronic morphine treatment","volume":"8","author":"Rubino","year":"1997","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0076","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"Savinainen","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0077","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.11.023","article-title":"Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors","volume":"1312","author":"Scavone","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2023.115586_bib0078","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","article-title":"Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal","volume":"248","author":"Scavone","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.psychres.2023.115586_bib0079","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41386-020-00888-1","article-title":"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study","volume":"46","author":"Schmidt","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.psychres.2023.115586_bib0081","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1523\/JNEUROSCI.20-12-04555.2000","article-title":"Chronic heroin self-administration desensitizes \u03bc opioid receptor-activated G-proteins in specific regions of rat brain","volume":"20","author":"Sim-Selley","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0082","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1523\/JNEUROSCI.2458-17.2017","article-title":"Are cocaine-seeking \u201chabits\u201d necessary for the development of addiction-like behavior in rats?","volume":"38","author":"Singer","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2023.115586_bib0083","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1441.030","article-title":"Chronic stress, drug use, and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.psychres.2023.115586_bib0084","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2017.05.031","article-title":"The endocannabinoid system as a target for addiction treatment: trials and tribulations","volume":"124","author":"Sloan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41401-018-0081-z","article-title":"Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies","volume":"40","author":"Sloan","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.psychres.2023.115586_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107733","article-title":"Nonhuman animal models of substance use disorders: translational value and utility to basic science","volume":"206","author":"Smith","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.psychres.2023.115586_bib0087","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir. Med. J."},{"issue":"7","key":"10.1016\/j.psychres.2023.115586_bib0088","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamapsychiatry.2021.0259","article-title":"Moving beyond medications that act at the mu receptor in the treatment of opioid use disorder","volume":"78","author":"Strain","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2023.115586_bib0089","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tics.2015.06.007","article-title":"Circuitry of self-control and its role in reducing addiction","volume":"19","author":"Tang","year":"2015","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.psychres.2023.115586_bib0090","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/361590","article-title":"The design of a quantitative western blot experiment","volume":"2014","author":"Taylor","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.psychres.2023.115586_bib0091","first-page":"655","article-title":"Functional assays for screening GPCR targets","volume":"16","author":"Thomsen","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0092","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2007.09.001","article-title":"Microdialysis and the neurochemistry of addiction","volume":"90","author":"Torregrossa","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0093","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13989","article-title":"The neurobiology of addiction","volume":"1451","author":"Uhl","year":"2019","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0094","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.1973.04200020065009","article-title":"A 20-year follow-up of New York narcotic addicts","volume":"29","author":"Vaillant","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2023.115586_bib0095","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.psychres.2023.115586_bib0096","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.npp.1300117","article-title":"Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain","volume":"28","author":"Vigano","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2023.115586_bib0097","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigano","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.psychres.2023.115586_bib0098","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1460-9568.2004.03645.x","article-title":"Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine","volume":"20","author":"Vigano","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0099","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0100","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2017.126","article-title":"Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling","volume":"43","author":"Wenzel","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2023.115586_bib0102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/can.2018.0022","article-title":"Emerging evidence for cannabis' role in opioid use disorder","volume":"3","author":"Wiese","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"issue":"22","key":"10.1016\/j.psychres.2023.115586_bib0103","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1007\/s00213-014-3575-5","article-title":"CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats","volume":"231","author":"Wills","year":"2014","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.psychres.2023.115586_bib0104","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1530-0277.2010.01215.x","article-title":"Insight into the relationship between impulsivity and substance abuse from studies using animal models","volume":"34","author":"Winstanley","year":"2010","journal-title":"Alcoholism: Clin. Exp. Res."},{"key":"10.1016\/j.psychres.2023.115586_bib0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2013.07.047","article-title":"Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal","volume":"1531","author":"Yuan","year":"2013","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0106","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2023.115586_bib0107","article-title":"The effects of repeated morphine treatment on the endogenous cannabinoid system in the ventral tegmental area","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115586_bib0108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.07.047","article-title":"Blockade of cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus","volume":"630","author":"Zhang","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.psychres.2023.115586_bib0109","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jpain.2018.04.009","article-title":"Effects of cannabinoid type 2 receptor agonist AM1241 on morphine-induced antinociception, acute and chronic tolerance, and dependence in mice","volume":"19","author":"Zhang","year":"2018","journal-title":"J. Pain"},{"issue":"4","key":"10.1016\/j.psychres.2023.115586_bib0110","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1213\/ANE.0000000000001129","article-title":"Low-dose cannabinoid type 2 receptor agonist attenuates tolerance to repeated morphine administration via regulating \u03bc-opioid receptor expression in walker 256 tumor-bearing rats","volume":"122","author":"Zhang","year":"2016","journal-title":"Anesth. Analgesia"},{"issue":"1\u20132","key":"10.1016\/j.psychres.2023.115586_bib0111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2012.04.003","article-title":"Exposure to morphine affects the expression of endocannabinoid receptors and immune functions","volume":"247","author":"Zhang","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.psychres.2023.115586_bib0112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/WNR.0000000000000796","article-title":"Cannabinoid 1 receptor blockade in the dorsal hippocampus prevents the reinstatement but not acquisition of morphine-induced conditioned place preference in rats","volume":"28","author":"Zhao","year":"2017","journal-title":"Neuroreport"},{"issue":"11","key":"10.1016\/j.psychres.2023.115586_bib0113","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbalip.2011.08.004","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective","volume":"1811","author":"Zoerner","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.psychres.2023.115586_bib0114","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812300536X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812300536X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:01:26Z","timestamp":1759039286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812300536X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":114,"alternative-id":["S016517812300536X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115586","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of the endogenous cannabinoid system following opioid exposure","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115586"}}